NIH State-of-the-Science Conference:
Role of Active Surveillance in the
Management of Men With
Localized Prostate Cancer
December 5–7, 2011
Bethesda, Maryland
Conference Home
Draft Statement
Program & Abstracts | PDF
Evidence Report
Planning Committee | Panel
Continuing Education
Documents in PDF format require the Adobe Acrobat Reader®.
If you experience problems with PDF documents, please download
the latest version of the Reader®.
Panel Biographies
Patricia A. Ganz, M.D.
Panel and Conference Chairperson
Dr. Ganz is Professor of Health Services in the University of California, Los Angeles (UCLA) School of Public Health, Professor of Medicine in the David Geffen School of Medicine at UCLA, and Director of the Division of Cancer Prevention and Control Research at the Jonsson Comprehensive Cancer Center. She teaches healthcare practices and variations and ethical issues in public health. Dr. Ganz received her M.D. from the UCLA School of Medicine in 1973 and completed postdoctoral training in internal medicine and medical oncology at the UCLA Medical Center. She has been on the faculty of the School of Medicine since 1977 and joined the faculty of the School of Public Health in 1992. Dr. Ganz has devoted the past 30 years to the study of quality-of-life outcomes in cancer and other chronic diseases. She has conducted federally funded research for nearly three decades and has led several large clinical intervention trials in breast cancer. Her current research focuses on the late effects of cancer treatment and improving the quality of care for cancer survivors.
Dr. Ganz is Associate Editor of the Journal of the National Cancer Institute and a member of the editorial board of the Cochrane Breast Cancer Group. In 1999, she was named an American Cancer Society Clinical Research Professor; in 2007, she became a member of the National Academy of Sciences Institute of Medicine.
John M. Barry, M.D.
Dr. Barry is Emeritus Professor of Surgery in the Divisions of Urology and Abdominal Organ Transplantation at Oregon Health & Science University. He was Director of Kidney Transplantation from 1976 to 2009, Head of the Division of Abdominal Organ Transplantation from 1990 to 1992, and Head of the Division of Urology and Renal Transplantation from 1980 to 2008. Dr. Barry’s specialty areas are kidney transplantation, surgical diseases of the kidney, erectile dysfunction, Peyronie’s disease, and reconstructive urology.
Wylie Burke, M.D., Ph.D.
Dr. Burke is Professor and Chair of the Department of Bioethics and Humanities at the University of Washington. She was the founding Director of the University of Washington’s Women’s Health Care Center and serves as Principal Investigator for the Center for Genomics and Healthcare Equality, a Center of Excellence in Ethical, Legal, and Social Issues Research funded by the National Human Genome Research Institute. Dr. Burke’s research interests include evaluation of the ethical, legal, and policy implications of genetics in medicine, research, and public health.
Nananda F. Col, M.D., M.P.P., M.P.H., FACP
Dr. Col is a primary care internist and Professor of Medicine at the Center for Excellence in the Neurosciences and the Departments of Family Medicine and Geriatric Medicine at the University of New England. She is also President of Shared Decision Making Resources and has served on several committees, including the Food and Drug Administration Risk Communication Advisory Committee, the International Patient Decision Aid Standards Collaboration Steering Committee, and the Institute of Medicine’s Committee on Women’s Health Research. Dr. Col’s research interests include shared decision-making, personalized decision support, and risk communication.
Nananda F. Col, M.D., M.P.P., M.P.H., FACP
Dr. Col is a Professor of Medicine at the Center for Excellence in the Neurosciences and the Departments of Family Medicine and Geriatric Medicine at the University of New England. She is also President of Shared Decision Making Resources and has served on several committees, including the Food and Drug Administration Risk Communication Advisory Committee, the International Patient Decision Aid Standards Collaboration Steering Committee, and the Institute of Medicine’s Committee on Women’s Health Research. Dr. Col’s research interests include shared decision-making, personalized decision support, and risk communication.
Phaedra S. Corso, Ph.D., M.P.A.
Dr. Corso is Professor and Head of the Department of Health Policy and Management in the College of Public Health at the University of Georgia (UGA). Prior to joining the UGA faculty, she worked for 15 years at the Centers for Disease Control and Prevention as an economic and policy analyst. Dr. Corso’s research interests include the economic evaluation of public health interventions; quality of life assessment for vulnerable populations; evaluation of preferences for health risks; and violence, injury, and substance use prevention.
Everett Dodson
Mr. Dodson is a Community Health Educator at the Lombardi Comprehensive Cancer Center at Georgetown University. He is a former member of the National Cancer Institute’s Clinical Trials Advisory Committee and Patient Advocate Steering Committee, and is the former Vice Chair of the Director’s Consumer Liaison Group. Mr. Dodson is also a former Chairperson for the Mid- Atlantic Region of the National Black Leadership Initiative on Cancer. His interests include community engagement and men’s health issues.
M. Elizabeth Hammond, M.D.
Dr. Hammond is a Professor of Pathology at the University of Utah School of Medicine, a Pathologist at Intermountain Healthcare, and Executive Editor for Pathology Products at Amirsys, Inc. She is the Director of Transplant Pathology for the Utah Transplantation Affiliated Hospitals Cardiac Transplant Program. Dr. Hammond’s research focuses on immune responses to cancer, humorally mediated cardiac transplant rejection, and predictive cancer tests (including molecular genetic tests).
Barry A. Kogan, M.D., FAAP, FACS
Dr. Kogan is Chief of the Division of Urology and Professor of Urology and Pediatrics at Albany Medical College. He has served as an expert for many professional societies, including the American Academy of Pediatrics, the National Kidney Foundation, the European Society of Pediatric Urology, and the American Urological Association. Dr. Kogan’s medical interests include pediatric urology, genital and urinary tract reconstruction, and prenatal urinary problems.
Charles F. Lynch, M.D., Ph.D., M.S.
Dr. Lynch is a Professor and Associate Head of Research for the Department of Epidemiology in the College of Public Health at the University of Iowa. He is also Medical Director and Principal Investigator at the State Health Registry of Iowa and Leader of the Cancer Epidemiology Program at the Holden Comprehensive Cancer Center. Dr. Lynch’s research interests include carcinogenesis, cancer surveillance, population studies, and environmental epidemiology.
Lee Newcomer, M.D.
Dr. Newcomer is Senior Vice President of Oncology, Genetics, and Women’s Health at United Healthcare. He is a board-certified medical oncologist and practiced for 10 years in Tulsa, Oklahoma. He formerly served as Chairman of Park Nicollet Health Services and remains on their board. Dr. Newcomer’s work has focused on the development of performance measures and incentives to improve clinical care.
Eric J. Seifter, M.D., FACP
Dr. Seifter is in a private multidisciplinary practice for internal medicine, focusing on medical oncology and hematologic malignancies. He is an Associate Professor of Medicine and Oncology at The Johns Hopkins University School of Medicine. He completed his fellowship at the Medical Oncology Branch of the National Cancer Institute and his internship and residency at Johns Hopkins Hospital. Some of Dr. Seifter’s current activities include Board Editor for the National Cancer Institute’s Physicians Data Query (PDQ®), Medicare Carrier Advisor for Medical Oncology for the J12 Jurisdiction, Director of the Lymphoma Conference at Johns Hopkins Hospital, Secretary and Board of Directors’ Member for the Maryland DC Society of Clinical Oncology, and Advisory Board Member for the Blue Cross/ Blue Shield P4 Pathways Program.
Janet A. Tooze, Ph.D., M.P.H.
Dr. Tooze is an Associate Professor in the Department of Biostatistical Sciences in the Division of Public Health Sciences at Wake Forest School of Medicine. She is also a Senior Biostatistician in the Biostatistics Core of the Comprehensive Cancer Center at Wake Forest University. She previously served as a Cancer Prevention Fellow in the Division of Cancer Prevention at the National Cancer Institute. Dr. Tooze’s research interests include physical fitness and exercise prescription, cancer prevention, epidemiology, and nutrition.
Kasisomayajula “Vish” Viswanath, Ph.D.
Dr. Viswanath is an Associate Professor at the Harvard School of Public Health and the Department of Medical Oncology at the Dana-Farber Cancer Institute, where he also serves as Director of the Health Communication Core of the Dana-Farber/Harvard Cancer Center. Dr. Viswanath’s work, drawing from literatures in communication science, social epidemiology, and social and health behavior sciences, focuses on translational communication science to influence public health policy and practice with a particular emphasis on communication inequalities and disparities in public and individual health in diverse populations.
Hunter Wessells, M.D., FACS
Dr. Wessells is Professor and Chair of the Department of Urology, and the Nelson Chair in Urology at University of Washington School of Medicine. He is also a member of the American College of Surgeons Advisory Committee for Urology and the American Urological Association Urotrauma Guidelines Panel. Dr. Wessells’ clinical interests cover a wide range of subjects in urology, from acute urogenital injury management to complex lower urinary tract reconstruction. His research interests include the pathophysiology and genetics of erectile dysfunction, urological complications of diabetes, and mechanisms of urological trauma.
 |
Learn more about the NIH Consensus Development Program | |
| Join the Consensus Development Program Information Network | ||
Back to top
Contact Consensus Program |
Privacy Notice |
Disclaimer |
Accessibility |
Contact NIH
